Literature DB >> 31597550

Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study.

Yuesong Pan1, Hao Li1, Yilong Wang1, Xia Meng1, Yongjun Wang1.   

Abstract

Background and Purpose- Stroke and Alzheimer disease are 2 major causes of neurological disability in aged people and shared overlapping predictors. In recent prospective studies, high Lp(a) [lipoprotein(a)] level is associated with high risk of stroke but low risk of Alzheimer disease. Whether this reflects a causal association remains to be established. The aim of this study is to examine the causal associations of Lp(a) concentrations on ischemic stroke, ischemic stroke subtypes, and Alzheimer disease. Methods- We used 9 single-nucleotide polymorphisms associated with Lp(a) concentrations as instrumental variables. Summary-level data on ischemic stroke and its subtypes were obtained from the Multiancestry Genome-Wide Association Study of Stroke consortium with European individuals ≤446 696 individuals. Summary-level data on Alzheimer disease were obtained from the International Genomics of Alzheimer Project With European individuals ≤54 162 individuals. Two-sample Mendelian randomization (MR) estimates were calculated with inverse-variance weighted, penalized inverse-variance weighted, simple median, weighted median, and MR Pleiotropy Residual Sum and Outlier approaches, and MR-Egger regression was used to explore pleiotropy. Results- Genetically predicted 1-SD log-transformed increase in Lp(a) concentrations was associated with a substantial increase in risk of large artery stroke (odds ratio, 1.20; 95% CI, 1.11-1.30; P<0.001) and a reduce in risk of small vessel stroke (odds ratio, 0.92; 95% CI, 0.88-0.97; P=0.001) and Alzheimer disease (odds ratio, 0.94; 95% CI, 0.91-0.97; P<0.001) using inverse-variance weighted method. No significant association was observed for total ischemic stroke or cardioembolic stroke. MR-Egger indicated no evidence of pleiotropic bias. Results were broadly consistent in sensitivity analyses using penalized inverse-variance weighted, simple median, weighted median, and MR Pleiotropy Residual Sum and Outlier approaches accounting for potential genetic pleiotropy or outliers. Conclusions- This study provides evidence to support that high Lp(a) concentrations was causally associated with an increased risk of large artery stroke but a decreased risk of small vessel stroke and Alzheimer disease. The mechanism underlying the double-edged sword effect of Lp(a) concentrations on neurological system requires further investigation.

Entities:  

Keywords:  humans; lipoprotein(a); odds ratio; risk; stroke

Year:  2019        PMID: 31597550     DOI: 10.1161/STROKEAHA.119.026872

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

Review 1.  Genetics of common cerebral small vessel disease.

Authors:  Constance Bordes; Muralidharan Sargurupremraj; Aniket Mishra; Stéphanie Debette
Journal:  Nat Rev Neurol       Date:  2022-01-05       Impact factor: 42.937

2.  New Strategies for Lowering Low Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention.

Authors:  Sean Paul Gaine; Renato Quispe; Jaideep Patel; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2022-06-25

Review 3.  Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection.

Authors:  Pamila Dua; Archana Mishra; K H Reeta
Journal:  Biomark Med       Date:  2022-06-13       Impact factor: 2.498

4.  Relationship Between Lipoprotein (a) [Lp(a)] and Cognition in Different Ischemic Stroke Subtypes.

Authors:  Jingjing Li; Shiyu Li; Yuesong Pan; Mengxing Wang; Xia Meng; Yilong Wang; Xingquan Zhao; Yongjun Wang
Journal:  Front Neurol       Date:  2021-12-03       Impact factor: 4.003

5.  Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease.

Authors:  Fadia Mayyas; Eman Bani Omar
Journal:  Heliyon       Date:  2022-06-30

Review 6.  Genome-Wide Studies in Ischaemic Stroke: Are Genetics Only Useful for Finding Genes?

Authors:  Cristina Gallego-Fabrega; Elena Muiño; Jara Cárcel-Márquez; Laia Llucià-Carol; Miquel Lledós; Jesús M Martín-Campos; Natalia Cullell; Israel Fernández-Cadenas
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

7.  Lipoprotein (a) levels and vulnerable characteristics in nonculprit plaque in patients with acute coronary syndrome.

Authors:  Ayami Kato; Daisuke Kinoshita; Takako Nagata; Kiyoshi Asakura; Masahiro Katamine; Aritomo Katsura; Takuya Hashimoto; Yoshiyasu Minami; Junya Ako
Journal:  Int J Cardiol Heart Vasc       Date:  2022-09-08

8.  Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study.

Authors:  Juan Xia; Chunyue Guo; Kuo Liu; Yunyi Xie; Han Cao; Wenjuan Peng; Yanyan Sun; Xiaohui Liu; Bingxiao Li; Ling Zhang
Journal:  Lipids Health Dis       Date:  2021-06-01       Impact factor: 3.876

Review 9.  Relationship between lipoproteins, thrombosis, and atrial fibrillation.

Authors:  Wern Yew Ding; Majd B Protty; Ian G Davies; Gregory Y H Lip
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

Review 10.  Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics.

Authors:  Daniel I Swerdlow; David A Rider; Arash Yavari; Marie Wikström Lindholm; Giles V Campion; Steven E Nissen
Journal:  Cardiovasc Res       Date:  2022-03-25       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.